| Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020 | 1718 | 2020 |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016 | 1143 | 2016 |
| Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties C Coulouarn, VM Factor, JB Andersen, ME Durkin, SS Thorgeirsson Oncogene 28 (40), 3526-3536, 2009 | 913 | 2009 |
| Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ... Cell reports 18 (11), 2780-2794, 2017 | 668 | 2017 |
| Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors JB Andersen, B Spee, BR Blechacz, I Avital, M Komuta, A Barbour, ... Gastroenterology 142 (4), 1021-1031. e15, 2012 | 589 | 2012 |
| Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients L Quagliata, MS Matter, S Piscuoglio, L Arabi, C Ruiz, A Procino, M Kovac, ... Hepatology 59 (3), 911-923, 2014 | 448 | 2014 |
| Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas P Wang, Q Dong, C Zhang, PF Kuan, Y Liu, WR Jeck, JB Andersen, ... Oncogene 32 (25), 3091-3100, 2013 | 448 | 2013 |
| Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma J Chaisaingmongkol, A Budhu, H Dang, S Rabibhadana, B Pupacdi, ... Cancer cell 32 (1), 57-70. e3, 2017 | 368 | 2017 |
| Functional and genetic deconstruction of the cellular origin in liver cancer JU Marquardt, JB Andersen, SS Thorgeirsson Nature Reviews Cancer 15 (11), 653-667, 2015 | 353 | 2015 |
| Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends MS Matter, T Decaens, JB Andersen, SS Thorgeirsson Journal of hepatology 60 (4), 855-865, 2014 | 324 | 2014 |
| Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer JU Marquardt, L Gomez-Quiroz, LOA Camacho, F Pinna, YH Lee, ... Journal of hepatology 63 (3), 661-669, 2015 | 319 | 2015 |
| p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer DF Tschaharganeh, W Xue, DF Calvisi, M Evert, TV Michurina, LE Dow, ... Cell 158 (3), 579-592, 2014 | 255 | 2014 |
| Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma N Oishi, MR Kumar, S Roessler, J Ji, M Forgues, A Budhu, X Zhao, ... Hepatology 56 (5), 1792-1803, 2012 | 253 | 2012 |
| Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway P Viatour, U Ehmer, LA Saddic, C Dorrell, JB Andersen, C Lin, AF Zmoos, ... Journal of experimental medicine 208 (10), 1963-1976, 2011 | 238 | 2011 |
| Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types Á Holczbauer, VM Factor, JB Andersen, JU Marquardt, DE Kleiner, ... Gastroenterology 145 (1), 221-231, 2013 | 208 | 2013 |
| Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry L Izquierdo-Sanchez, A Lamarca, A La Casta, S Buettner, K Utpatel, ... Journal of hepatology 76 (5), 1109-1121, 2022 | 190 | 2022 |
| Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature Reviews Gastroenterology & Hepatology 13 (5), 261-280, 2016 | 182 | 2016 |
| Metabolic rearrangements in primary liver cancers: cause and consequences L Satriano, M Lewinska, PM Rodrigues, JM Banales, JB Andersen Nature reviews Gastroenterology & hepatology 16 (12), 748-766, 2019 | 178 | 2019 |
| Lipid alterations in chronic liver disease and liver cancer B Paul, M Lewinska, JB Andersen JHEP reports 4 (6), 100479, 2022 | 156 | 2022 |
| Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages C Raggi, M Correnti, A Sica, JB Andersen, V Cardinale, D Alvaro, ... Journal of hepatology 66 (1), 102-115, 2017 | 154 | 2017 |
Chiara RaggiUniversity of FlorenceVerified email at unifi.it
